Medical Imaging Reagents Market (Class: Contrast Reagents, Optical Reagents & Nuclear Reagents; Technology: Nanoparticles, Fluorescent Proteins, Fluorescent Dyes & Probes, Radiopharmaceuticals & Quantum Dots) - Global Industry Analysis, Size, Share, Growt

News provided by

Jun 11, 2014, 12:33 ET

NEW YORK, June 11, 2014
/PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Medical Imaging Reagents Market (Class: Contrast Reagents, Optical Reagents & Nuclear Reagents; Technology: Nanoparticles, Fluorescent Proteins, Fluorescent Dyes & Probes, Radiopharmaceuticals & Quantum Dots) - Global Industry Analysis, Size, Share, Growt

http://www.reportlinker.com/p02162958/Medical-Imaging-Reagents-Market-Class-Contrast-Reagents-Optical-Reagents--Nuclear-Reagents-Technology-Nanoparticles-Fluorescent-Proteins-Fluorescent-Dyes--Probes-Radiopharmaceuticals--Quantum-Dots---Global-Industry-Analysis-Size-Share-Growt.html

Medical Imaging Reagents Market (Class: Contrast Reagents, Optical Reagents and Nuclear Reagents; Technology: Nanoparticles, Fluorescent Proteins, Fluorescent Dyes and Probes, Radiopharmaceuticals and Quantum Dots & Application: Diagnostics, Drug Discovery and Development and Research and Development) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

A surge in the number of cancer and cardiovascular patients globally has prompted the growth of the medical imaging reagents market. Medical imaging reagents play a significant role in diagnostic, pharmaceuticals, biotechnology medical and life science industries. These reagents allow clinicians and healthcare providers to determine whether a tumor is malignant or benign and enables to locate any metastatic cancerous sites in the body. Medical imaging reagents are specially designed chemical compounds used to enhance images produced through imaging systems.

The medical imaging reagents market has been primarily segmented by class, technology and applications. On the basis of product class, the medical imaging reagents market comprises contrast reagents, optical reagents and nuclear reagents. Moreover, the technology segment of this market includes nanoparticles, fluorescent proteins, radiopharmaceuticals, quantum dots, fluorescent dyes and probes. Furthermore, applications market for medical imaging reagents consists of diagnostics, drug discovery and development as well as research and development. The market analysis of the above segments in terms of revenue and forecast (USD Million) has been provided in this report for the period 2011 – 2019. Moreover, this report also includes the respective compounded annual growth rate (CAGR %) for the above segments for the period 2013 – 2019, considering 2012 as the base year.

This research report on medical imaging reagents helps in understanding various market dynamics, such as the drivers, restraints and opportunities responsible for market growth. The market overview section of the report also includes qualitative analysis such as market attractiveness analysis and Porter's five forces model which assist in understanding the overall competition prevalent in the market.

The research report provides in-depth analysis of the medical imaging reagents market in major geographies such as North America, Europe, Asia and RoW. The market revenue and forecast for all the four regional markets for the period 2011 – 2019 along with their respective CAGRs are also included in this report. The report provides company profiles of major players in the market. Additionally, detailed market share analysis has been provided of the leading players along with strategic recommendations for the new market entrants and the existing market players. Some of the major market players profiled in this report include Bayer Healthcare AG, Bracco Imaging SpA, GE Healthcare, Lantheus Medical Imaging, Inc., Mallinckrodt Pharmaceuticals, Siemens Healthcare, Thermo Fisher Scientific, Inc. and others.

Chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.3.1 Sources
1.3.2 Assumptions

Chapter 2 Executive Summary
2.1 Market Snapshot: Global Medical Imaging Reagents Market

Chapter 3 Market Overview
3.1 Introduction and Market Definition
3.2 Market Dynamics
3.2.1 Market Drivers
3.2.1.1 Growing number of elderly population expected to drive market growth
3.2.1.2 Increasing prevalence rate of cancer, cardiovascular and neurological diseases expected to trigger market growth
3.2.1.3 Escalating demand for diagnostic imaging procedures influences imaging reagents sales
3.2.1.4 Technological development likely to spur the growth of the imaging reagents market
3.2.2 Market Restraints
3.2.2.1 Shortage of supplies of imaging reagents impede the growth of the market
3.2.2.2 Stringent regulatory approvals likely to hamper the market growth
3.2.2.3 Reluctance in adopting nuclear products restrict the market growth
3.2.3 Market Opportunities
3.2.3.1 Strengthening distribution network in emerging markets
3.2.3.2 Development of nuclear products based personalized therapy
3.3 Porter's Five Forces Analysis
3.3.1 Bargaining Power of Suppliers
3.3.2 Bargaining Power of Buyers
3.3.3 Threat of New Entrants
3.3.4 Threat of Substitutes
3.3.5 Competitive Rivalry
3.4 Market Attractiveness Analysis: Global Medical Imaging Reagents Market, by Geography
3.5 Market Share Analysis for Global Medical Imaging Reagents, by Key Players, 2012 (Value %)

Chapter 4 Global Medical Imaging Reagents Market, by Class
4.1 Overview
4.1.1 Global Medical Imaging Reagents Market Revenue, by Class, 2011 – 2019 (USD Million)
4.2 Contrast Reagents
4.2.1 Global Contrast Reagents Market Revenue, 2011 – 2019 (USD Million)
4.3 Optical Reagents
4.3.1 Global Optical Reagents Market Revenue, 2011 – 2019 (USD Million)
4.4 Nuclear Reagents
4.4.1 Global Nuclear Reagents Market Revenue, 2011 – 2019 (USD Million)

Chapter 5 Global Medical Imaging Reagents Market, by Technology
5.1 Overview
5.1.1 Global Medical Imaging Reagents Market Revenue, by Technology, 2011 – 2019 (USD Million)
5.2 Nanoparticles
5.2.1 Global Nanoparticles Market Revenue, 2011 – 2019 (USD Million)
5.3 Fluorescent Proteins
5.3.1 Global Fluorescent Proteins Market Revenue, 2011 – 2019 (USD Million)
5.4 Fluorescent Dyes and Probes
5.4.1 Global Fluorescent Dyes and Probes Market Revenue, 2011 – 2019 (USD Million)
5.5 Radiopharmaceuticals
5.5.1 Global Radiopharmaceuticals Market Revenue, 2011 – 2019 (USD Million)
5.6 Quantum Dots
5.6.1 Global Quantum Dots Market Revenue, 2011 – 2019 (USD Million)

Chapter 6 Global Medical Imaging Reagents Market, by Application
6.1 Overview
6.1.1 Global Medical Imaging Reagents Market Revenue, by Application, 2011 – 2019 (USD Million)
6.2 Diagnostics
6.2.1 Global Diagnostics Market Revenue, 2011 – 2019 (USD Million)
6.3 Drug Discovery and Development
6.3.1 Global Drug Discovery and Development Market Revenue, 2011 – 2019 (USD Million)
6.4 Research and Development
6.4.1 Global Research and Development Market Revenue, 2011 – 2019 (USD Million)

Chapter 7 Global Medical Imaging Reagents Market, by Geography
7.1 Overview
7.1.1 Global Medical Imaging Reagents Market Revenue, by Geography, 2011 – 2019 (USD Million)
7.2 North America
7.2.1 North America Medical Imaging Reagents Market Revenue, 2011 – 2019 (USD Million)
7.3 Europe
7.3.1 Europe Medical Imaging Reagents Market Revenue, 2011 – 2019 (USD Million)
7.4 Asia Pacific
7.4.1 Asia-Pacific Medical Imaging Reagents Market Revenue, 2011 – 2019 (USD Million)
7.5 Rest of the World (RoW)
7.5.1 RoW Medical Imaging Reagents Market Revenue, 2011 – 2019 (USD Million)

Chapter 8 Recommendations
8.1 Market Strategy for Success
8.2 Barriers to be Considered

Chapter 9 Company Profiles
9.1 Bayer Healthcare AG
9.1.1 Company Overview
9.1.2 Financial Overview
9.1.3 Product Portfolio
9.1.4 Business Strategies
9.1.5 Recent Developments
9.2 Beckman Coulter, Inc.
9.2.1 Company Overview
9.2.2 Financial Overview
9.2.3 Product Portfolio
9.2.4 Business Strategies
9.2.5 Recent Developments
9.3 Becton Dickinson & Company
9.3.1 Company Overview
9.3.2 Financial Overview
9.3.3 Product Portfolio
9.3.4 Business Strategies
9.4 Bracco Imaging SpA
9.4.1 Company Overview
9.4.2 Financial Overview
9.4.3 Product Portfolio
9.4.4 Business Strategies
9.4.5 Recent Developments
9.5 Cardinal Health, Inc.
9.5.1 Company Overview
9.5.2 Financial Overview
9.5.3 Product Portfolio
9.5.4 Business Strategies
9.5.5 Recent Developments
9.6 Lantheus Medical Imaging, Inc.
9.6.1 Company Overview
9.6.2 Financial Overview
9.6.3 Product Portfolio
9.6.4 Business Strategies
9.6.5 Recent Developments
9.7 Mallinckrodt Pharmaceuticals
9.7.1 Company Overview
9.7.2 Financial Overview
9.7.3 Product Portfolio
9.7.4 Business Strategies
9.7.5 Recent Developments
9.8 Promega Corporation
9.8.1 Company Overview
9.8.2 Financial Overview
9.8.3 Product Portfolio
9.8.4 Business Strategies
9.8.5 Recent Developments
9.9 Siemens Healthcare
9.9.1 Company Overview
9.9.2 Financial Overview
9.9.3 Product Portfolio
9.9.4 Business Strategies
9.9.5 Recent Developments
9.10 Thermo Fisher Scientific, Inc.
9.10.1 Company Overview
9.10.2 Financial Overview
9.10.3 Product Portfolio
9.10.4 Business Strategies
9.10.5 Recent Developments

List of Figures

FIG. 1 Medical Imaging Reagents Market Segmentation
FIG. 2 Global Medical Imaging Reagents Market, by Class, 2012 (USD Million)
FIG. 3 Global Medical Imaging Reagents Market, by Technology, 2012 (USD Million)
FIG. 4 Global Medical Imaging Reagents Market, by Application, 2012 (USD Million)
FIG. 5 Comparative Analysis: Global Medical Imaging Reagents Market, by Geography, 2012 & 2019 (Value %)
FIG. 6 Global Medical Imaging Reagents Market: Drivers and Restraints
FIG. 7 Porter's Five Forces Analysis: Global Medical Imaging Reagents Market
FIG. 8 Market Attractiveness Analysis: Global Medical Imaging Reagents Market, by Geography
FIG. 9 Market Share Analysis: Global Medical Imaging Reagents Market, by Key
Players, 2012 (Value %)
FIG. 10 Global Contrast Reagents Market Revenue, 2011 – 2019 (USD Million)
FIG. 11 Global Optical Reagents Market Revenue, 2011 – 2019 (USD Million)
FIG. 12 Global Nuclear Reagents Market Revenue, 2011 – 2019 (USD Million)
FIG. 13 Global Nanoparticles Market Revenue, 2011 – 2019 (USD Million)
FIG. 14 Global Fluorescent Proteins Market Revenue, 2011 – 2019 (USD Million)
FIG. 15 Global Fluorescent Dyes and Probes Market Revenue, 2011 – 2019 (USD Million)
FIG. 16 Global Radiopharmaceuticals Market Revenue, 2011 – 2019 (USD Million)
FIG. 17 Global Quantum Dots Market Revenue, 2011 – 2019 (USD Million)
FIG. 18 Global Diagnostics Market Revenue, 2011 – 2019 (USD Million)
FIG. 19 Global Drug Discovery and Development Market Revenue, 2011 – 2019 (USD Million)
FIG. 20 Global Research and Development Market Revenue, 2011 – 2019 (USD Million)
FIG. 21 North America Medical Imaging Reagents Market Revenue, 2011 – 2019 (USD Million)
FIG. 22 Europe Medical Imaging Reagents Market Revenue, 2011 – 2019 (USD Million)
FIG. 23 Asia-Pacific Medical Imaging Reagents Market Revenue, 2011 – 2019 (USD Million)
FIG. 24 RoW Medical Imaging Reagents Market Revenue, 2011 – 2019 (USD Million)
FIG. 25 Bayer Healthcare AG, Annual Revenue: 2010 – 2012 (USD Million)
FIG. 26 Becton, Dickinson and Company, Annual Revenue: 2010 – 2012 (USD Million)
FIG. 27 Cardinal Health, Inc., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 28 Lantheus Medical Imaging, Inc., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 29 Mallinckrodt Pharmaceuticals, Annual Revenue: 2010 – 2012 (USD Million)
FIG. 30 Siemens Healthcare, Annual Revenue: 2010 – 2012 (USD Million)
FIG. 31 Thermo Fisher Scientific, Inc., Annual Revenue: 2010 – 2012 (USD Million)

List of Tables

TABLE 1 Market Snapshot: Global Medical Imaging Reagents Market
TABLE 2 Global Medical Imaging Reagents Market Revenue, by Class, 2011 – 2019 (USD Million)
TABLE 3 Global Medical Imaging Reagents Market Revenue, by Technology, 2011 – 2019 (USD Million)
TABLE 4 Global Medical Imaging Reagents Market Revenue, by Application, 2011 – 2019 (USD Million)
TABLE 5 Global Medical Imaging Reagents Market Revenue, by Geography, 2011 – 2019 (USD Million)